Page 84 - Patent Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patent coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patent Coverage Today - Breaking & Trending Today

iTWire - Boomi secures two patents for AI innovation

COMPANY NEWS: Boomi, the intelligent connectivity and automation leader, is proud to announce that it has been granted two new patents by the United S. ....

New South Wales , Ed Macosky , Artificial Intelligence Assisted Construction , Integration Processes , Shape Suggest , Quick Start , Integration Processe , Chat Bot System , Native Business , Retrieval Augmented Generation ,

Federal Circuit Denies Petition For Rehearing En Banc Filed By Cellect, LLC - Patent

The Federal Circuit denied Cellect, LLC's petition for rehearing en banc of the In re Cellect case, which held that the expiration of a patent for obviousness-type double patenting ("ODP") purposes. ....

Federal Circuit , Patent Trial , Appeal Board , Federal Circuit Denies Petition For Rehearing En Banc Filed By Cellect , Intellectual Property ,

Accord's ABLA For Proposed Biosimilar DMB-3115 Accepted By FDA - Life Sciences, Biotechnology & Nanotechnology

According to a January 2024 press release from Accord BioPharma, Inc. ("Accord"), the FDA accepted Accord's abbreviated Biologics License Application (aBLA). ....

United States , A Johnson , Seika Pharma , April Breyer Menon , Accord Biopharma Inc , Donga Socio Holdings , Intas Pharmaceuticals , Accord Biopharma , Biologics License , Janssen Biotech , Meiji Seika Pharma , Accord Amp 39s Abla For Proposed Biosimilar Dmb 3115 Accepted By Fda , Life Sciences , Food And Drugs Law , Life Sciences , Iotechnology Amp Nanotechnology , Intellectual Property ,

17 Challenges Every Inventor Must Conquer

Obstacles for inventors are numerous. Here s a snapshot of the challenges faced when commercializing something new. ....

Marc Randolph , Jim Pooley , Patent Pro Bono Program , Shark Tank , Expert Jim Pooley , Patent Trial , Appeal Board , Like Marc Randolph ,

USPTO Rejects

On January 18, 2024, the USPTO rejected a "contingent" terminal disclaimer filed by Acadia Pharmaceuticals Inc. (Acadia) for a patent it owns. ....

United States , Acadia Pharmaceuticals Inc , Pharmaceuticals Inc , Aurobindo Pharma Ltd , Acadia Pharmaceuticals , Abbreviated New Drug Application , Orange Book Listed , Patent Term Adjustment , Patent Term , Contingent Terminal Disclaimer , Terminal Disclaimer , Contingent Terminal , Federal Circuit , Uspto Rejects Quot Contingent Terminal Disclaimer , Intellectual Property , Ediation Amp Arbitration , Trials Amp Appeals Compensation ,